Exercise Pulmonary Hypertension in Heart Valve Disease
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
The optimal management of heart valve disease (HVD) is still debated and many studies are underway to identify the best time to refer patients for the most appropriate treatment strategy (either conservative, surgical or transcatheter interventions). Exercise pulmonary hypertension (PH) can be detected during exercise stress echocardiography (ESE) and has been demonstrated to have an important prognostic role in HVD, by predicting symptoms and mortality. This review article aims to provide an overview on the prognostic role of exercise PH in valvulopathies, and its possible role in the diagnostic-therapeutic algorithm for the management of HVD.
References
1.
Saito C, Arai K, Ashihara K, Niinami H, Hagiwara N
. Utility of dobutamine stress echocardiography in aortic valve regurgitation and reduced left ventricular function. Echocardiography. 2022; 39(4):599-605.
DOI: 10.1111/echo.15334.
View
2.
Adamo M, Fiorelli F, Melica B, DOrtona R, Lupi L, Giannini C
. COAPT-Like Profile Predicts Long-Term Outcomes in Patients With Secondary Mitral Regurgitation Undergoing MitraClip Implantation. JACC Cardiovasc Interv. 2020; 14(1):15-25.
DOI: 10.1016/j.jcin.2020.09.050.
View
3.
Ratwatte S, Strange G, Playford D, Stewart S, Celermajer D
. Prevalence of pulmonary hypertension in mitral regurgitation and its influence on outcomes. Open Heart. 2023; 10(1).
PMC: 10254941.
DOI: 10.1136/openhrt-2023-002268.
View
4.
Baumgartner H, Falk V, Bax J, De Bonis M, Hamm C, Holm P
. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017; 38(36):2739-2791.
DOI: 10.1093/eurheartj/ehx391.
View
5.
Magne J, Lancellotti P, Pierard L
. Exercise pulmonary hypertension in asymptomatic degenerative mitral regurgitation. Circulation. 2010; 122(1):33-41.
DOI: 10.1161/CIRCULATIONAHA.110.938241.
View